Seoul, South Korea

Seog Bae Oh

USPTO Granted Patents = 1 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Seog Bae Oh: Innovator in Pharmaceutical Composition

Introduction

Seog Bae Oh is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions aimed at treating various diseases and conditions related to TRPV1 activity and inflammation.

Latest Patents

Seog Bae Oh holds a patent for a pharmaceutical composition designed for preventing or treating TRPV1 activity-related and inflammation-related diseases. This composition contains a Maillard peptide separated from well-aged traditional soy sauce as its active ingredient. The Maillard peptide functions as both a TRPV1 agonist and antagonist, making it a versatile modulator of TRPV1 activity. This innovation can be utilized for a range of conditions, including pain, neurological diseases, and various inflammatory disorders.

Career Highlights

Throughout his career, Seog Bae Oh has worked with esteemed organizations such as the Korea Food Research Institute and the Snur & Db Foundation. His work has focused on the intersection of food science and pharmaceutical applications, showcasing his ability to bridge these two fields effectively.

Collaborations

Seog Bae Oh has collaborated with notable colleagues, including Mee-Ra Rhyu and Ah-Young Song. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.

Conclusion

Seog Bae Oh's innovative work in pharmaceutical compositions highlights the potential of traditional ingredients in modern medicine. His contributions are paving the way for new treatments for various health conditions, demonstrating the importance of innovation in the pharmaceutical industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…